BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31593572)

  • 1. Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene.
    Pierandrei S; Blaconà G; Fabrizzi B; Cimino G; Cirilli N; Caporelli N; Angeloni A; Cipolli M; Lucarelli M
    PLoS One; 2019; 14(10):e0222838. PubMed ID: 31593572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
    Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
    Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
    Sharma H; Mavuduru RS; Singh SK; Prasad R
    Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Characteristics of Patients with Cystic Fibrosis whose Genotype Includes a Variant of the Nucleotide Sequence c.3140-16T>A and Functional Analysis of this Variant.
    Kondratyeva E; Bukharova T; Efremova A; Melyanovskaya Y; Bulatenko N; Davydenko K; Filatova A; Skoblov M; Krasovsky S; Petrova N; Polyakov A; Adyan T; Amelina E; Shadrina V; Zhekaite E; Zodbinova A; Chernyak A; Zinchenko R; Kutsev S; Goldshtein D
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
    Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
    Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population.
    Tabaripour R; Niaki HA; Douki MR; Bazzaz JT; Larijani B; Yaghmaei P
    Dis Markers; 2012; 32(4):241-6. PubMed ID: 22430190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples.
    McGinniss MJ; Chen C; Redman JB; Buller A; Quan F; Peng M; Giusti R; Hantash FM; Huang D; Sun W; Strom CM
    Hum Genet; 2005 Dec; 118(3-4):331-8. PubMed ID: 16189704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short communication: novel truncating mutations in the CFTR gene causing a severe form of cystic fibrosis in Italian patients.
    Lenarduzzi S; Morgutti M; Crovella S; Coiana A; Rosatelli MC
    Genet Mol Res; 2014 Nov; 13(4):9636-41. PubMed ID: 25501174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.
    Straniero L; Soldà G; Costantino L; Seia M; Melotti P; Colombo C; Asselta R; Duga S
    J Hum Genet; 2016 Dec; 61(12):977-984. PubMed ID: 27488443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of exons 16-17b of CFTR is frequently identified in Korean patients with cystic fibrosis.
    Sohn YB; Ko JM; Jang JY; Seong MW; Park SS; Suh DI; Ko JS; Shin CH
    Eur J Med Genet; 2019 Aug; 62(8):103681. PubMed ID: 31136843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
    Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
    Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
    Felício V; Ramalho AS; Igreja S; Amaral MD
    Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.
    Terlizzi V; Castaldo G; Salvatore D; Lucarelli M; Raia V; Angioni A; Carnovale V; Cirilli N; Casciaro R; Colombo C; Di Lullo AM; Elce A; Iacotucci P; Comegna M; Scorza M; Lucidi V; Perfetti A; Cimino R; Quattrucci S; Seia M; Sofia VM; Zarrilli F; Amato F
    J Med Genet; 2017 Apr; 54(4):224-235. PubMed ID: 27738188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization and phenotypic spectrum of three recurrent disease-causing deep intronic variants of the CFTR gene.
    Bergougnoux A; Délétang K; Pommier A; Varilh J; Houriez F; Altieri JP; Koenig M; Férec C; Claustres M; Lalau G; Bienvenu T; Audrézet MP; Pagin A; Girodon E; Raynal C; Taulan-Cadars M
    J Cyst Fibros; 2019 Jul; 18(4):468-475. PubMed ID: 30389601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.
    Joynt AT; Evans TA; Pellicore MJ; Davis-Marcisak EF; Aksit MA; Eastman AC; Patel SU; Paul KC; Osorio DL; Bowling AD; Cotton CU; Raraigh KS; West NE; Merlo CA; Cutting GR; Sharma N
    PLoS Genet; 2020 Oct; 16(10):e1009100. PubMed ID: 33085659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
    Davies JC; Moskowitz SM; Brown C; Horsley A; Mall MA; McKone EF; Plant BJ; Prais D; Ramsey BW; Taylor-Cousar JL; Tullis E; Uluer A; McKee CM; Robertson S; Shilling RA; Simard C; Van Goor F; Waltz D; Xuan F; Young T; Rowe SM;
    N Engl J Med; 2018 Oct; 379(17):1599-1611. PubMed ID: 30334693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms.
    Audrézet MP; Chen JM; Raguénès O; Chuzhanova N; Giteau K; Le Maréchal C; Quéré I; Cooper DN; Férec C
    Hum Mutat; 2004 Apr; 23(4):343-57. PubMed ID: 15024729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.